RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -102.86% | -2,866.50% | -471.18% | -328.08% | -- |
| Total Depreciation and Amortization | 640.55% | 795.10% | 609.15% | 365.88% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 146.00% | 193.76% | 186.08% | 157.73% | -- |
| Change in Net Operating Assets | 170.49% | 75.38% | -4.97% | -926.80% | -- |
| Cash from Operations | 77.00% | -20.50% | -83.09% | -263.31% | -- |
| Capital Expenditure | -700.18% | -526.78% | -1,719.28% | -515.32% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -700.18% | -526.78% | -1,759.47% | -515.32% | -- |
| Total Debt Issued | 2,834.78% | 2,834.78% | 2,124.58% | 815.43% | -- |
| Total Debt Repaid | 70.24% | -43.25% | -61.09% | -61.05% | -- |
| Issuance of Common Stock | -100.00% | 12.04% | 119.45% | 274.14% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.83% | -2,176.39% | -10,845.83% | -10,845.83% | -- |
| Cash from Financing | -24.44% | 130.41% | 243.27% | 382.41% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.56% | 282.19% | 146.34% | 897.99% | -- |